IBP-9414 for the Prevention of Necrotizing Enterocolitis

NCT02472769 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Necrotizing Enterocolitis

Interventions

DRUG: IBP-9414
DRUG: Placebo

Sponsor

Infant Bacterial Therapeutics